|
|
|||
|
||||
OverviewThe synthetic anti-diabetic drugs have side effect, associated with, and high costs, limiting their accessibility, particularly in resource-constrained settings. The rising global burden of diabetes necessitates innovative approaches to identify safe, effective, and affordable treatments. In silico drug discovery provides a powerful platform to screen natural compounds against diabetes-related protein targets, significantly reducing the time and cost associated with traditional drug development. This research bridges the gap between traditional phytotherapy and modern computational drug design. Full Product DetailsAuthor: Kabir Suleiman KwanakiPublisher: Eliva Press Imprint: Eliva Press Dimensions: Width: 15.20cm , Height: 0.60cm , Length: 22.90cm Weight: 0.168kg ISBN: 9789999334808ISBN 10: 9999334806 Pages: 118 Publication Date: 01 January 2025 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||